XML 123 R104.htm IDEA: XBRL DOCUMENT v3.25.4
Condensed Financial Information of Registrant - Schedule of Condensed Statements of Cash Flows (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Other operating activities, net $ 75 $ 72 $ 168
Net cash provided by operating activities 5,088 154 8,053
Cash flows from investing activities:      
Purchases of investments (4,541) (7,183) (6,622)
Sales and maturities of investments 5,780 5,785 5,523
Net cash provided by (used in) investing activities 472 (1,052) (1,191)
Cash flows from financing activities:      
Proceeds from long-term debt 750 1,300 2,335
Payments and repurchases of long-term debt (1,895) (622) (2,316)
Common stock repurchases (475) (3,124) (1,633)
Proceeds from common stock issuances 37 46 44
Purchase of noncontrolling interest (19) 0 (88)
Other financing activities, net (19) (6) 0
Net cash used in financing activities (1,621) (2,406) (1,658)
Cash, cash equivalents and restricted cash and cash equivalents, beginning of period 14,156 17,452 12,330
Cash, cash equivalents and restricted cash and cash equivalents, end of period 17,957 14,156 17,452
Parent Company      
Cash flows from operating activities:      
Dividends from subsidiaries 1,671 1,797 2,823
Payments for legal settlement (41) (263) (326)
Other operating activities, net (584) (422) (334)
Net cash provided by operating activities 1,046 1,112 2,163
Cash flows from investing activities:      
Capital contributions to subsidiaries (2,001) (730) (443)
Purchases of investments (20) (2) (202)
Sales and maturities of investments 1 0 0
Return of capital from subsidiaries to parent company 1,599 321 85
Proceeds from divestitures 0 0 325
Intercompany activities 989 1,693 (357)
Net cash provided by (used in) investing activities 568 1,282 (592)
Cash flows from financing activities:      
Proceeds from long-term debt 750 1,300 2,305
Payments and repurchases of long-term debt (1,895) (610) (2,290)
Common stock repurchases (475) (3,124) (1,633)
Proceeds from common stock issuances 37 46 44
Purchase of noncontrolling interest (19) 0 0
Other financing activities, net (19) (6) (2)
Net cash used in financing activities (1,621) (2,394) (1,576)
Net increase (decrease) in cash and cash equivalents (7) 0 (5)
Cash, cash equivalents and restricted cash and cash equivalents, beginning of period 7 7 12
Cash, cash equivalents and restricted cash and cash equivalents, end of period $ 0 $ 7 $ 7